OCT 30, 2014 12:00 AM PDT

Cancer Study In Mice Brings Hope For Human Patients

A study conducted at the University of Chicago's Center for Personalized Therapeutics has shown remarkable results in eliminating human tumors that have been transplanted into mice. The new research, reported in the journal Science Translational Medicine, highlighted two drugs that were extremely effective and produced little or no side effects.

The drugs, OTS964 and its precursor OTS514, were given to mice that had been implanted with human cancer tumors. The drugs were given in two forms, intravenously and orally. Initially, the drugs showed toxicity to red and white blood cells, however once it was encased in liposomes, this toxicity was eliminated in the intravenous form and easily managed in the oral form.

The molecular target of this drug has been known for over a decade. TOPK (T-lymphocyte-activated killer cell-originated protein kinase) has always been associated with tumor growth. The protein is present in many kinds of human cancers, but the study looked at an especially aggressive lung tumor, LU-99. Researchers grew the tumors on the mice to 150 cubic millimeters and then injected the mice with OTS964, twice a week for three weeks. In five out of six of the mice, the tumors were completely eliminated. Even after the drug was stopped, the tumors continued to shrink.

The drug worked by preventing the tumor cells from dividing. TOPK is the agent that allows cancer cells to rapidly divide and spread disease. Without this protein, the cancer cells failed to divide and grow and essentially withered and died.

University of Chicago Professor of Medicine, Yusuke Nakamura, was excited by the results. "It is rare to see complete regression of tumors in a mouse model," he said. "Many drugs can repress the growth but it is uncommon to see them eradicated. This has rarely been reported."

Phase 1 clinical trials of the drug could begin as early as the fall of 2015
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
MAR 02, 2020
Genetics & Genomics
MAR 02, 2020
DNA Replication Discovery May Lead to New Cancer Treatments
Researchers have learned more about DNA replication during cell division, and their insights may help create new types o ...
MAR 29, 2020
Cancer
MAR 29, 2020
Improving ependymoma diagnostics
Have you ever heard of ependymoma? This rare form of brain cancer most commonly occurs in young children when tumors for ...
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
APR 21, 2020
Cancer
APR 21, 2020
Scientists develop tumor immunity map
A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecule ...
MAY 09, 2020
Cancer
MAY 09, 2020
Disney movies boost quality of life during chemo
Have you considered popping in a Disney movie during your next chemotherapy session? A study published recently in JAMA ...
MAY 14, 2020
Cancer
MAY 14, 2020
New hope for immunotherapy for pediatric brain cancer
Pediatric brain cancer is an especially tough pill to swallow. While one in four children does not survive medulloblasto ...
Loading Comments...